Amy Yule | Profiles RNS

Amy Yule, MD

Associate Professor

Boston University Chobanian & Avedisian School of Medicine

Psychiatry

MD, University of California, Los Angeles
BS, University of California, San Diego

Websites

	MassGeneral
	Harvard Catalyst
	Boston Medical Center Provider Profile
	ResearchGate

ORCID : 0000-0002-2409-9426

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research

BMC Research

Addiction Psychiatry Treatment Program, Office Based Addiction Treatment (OBAT) Expansion
04/01/2023 - 06/30/2026 (PI)
Massachusetts Dept. of Public Health / DPH

WRAP without Walls
11/01/2021 - 10/31/2024 (PI)
Jack Satter Foundation, Inc.

Does Treating Young Persons Psychopathology Prevent the Onset of Opioid and other Substance Use Disorders?
12/02/2019 - 08/31/2024 (PI)
Massachusetts General Hospital National Institute o
1UG3DA050252-01

Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
10/01/2022 - 12/31/2023 (PI)
Brown University National Institute o
7R01HD092456-03

AACAP Physician Scientist Program in Substance Abuse
12/02/2019 - 05/31/2021 (PI)
American Academy of Child and Adolescent Psychiatry National Institute o
2K12DA000357-21

Health Care and Safety Expert Consultants
04/15/2020 - 06/30/2020 (PI)
Massachusetts Dept. of Public Health / DPH

Title

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Schoenberger SF, Cummins ER, Carroll JJ, Yan S, Lambert A, Bagley SM, Xuan Z, Green TC, Cook F, Yule AM, Walley AY, Formica SW. "Wanna cry this out real quick?": an examination of secondary traumatic stress risk and resilience among post-overdose outreach staff in Massachusetts. Harm Reduct J. 2024 Mar 19; 21(1):66.View Related Profiles.

Walley, Alexander
Yule, Amy
Bagley, Sarah
Xuan, Ziming

PMID: 38504244; DOI: 10.1186/s12954-024-00975-2;

Kramer J, Perez D, Ramseier D, Morgan L, Wilens TE, Rao V, Yule AM. Patient Experiences Completing Patient Reported Outcome Measures in Behavioral Health Within a Health Safety-Net Setting. Community Ment Health J. 2024 Mar 02. PMID: 38430286

Marshall A, Fai C, Han J, Yule AM, Jangi S. Rising Inpatient Utilization and Costs of Cannabis Hyperemesis Syndrome Hospitalizations in Massachusetts After Cannabis Legalization. J Clin Gastroenterol. 2024 Mar 01; 58(3):247-252. PMID: 37224284

Yule AM, Youn SJ, Dean K, Woodward DW, Firmin ES, Kramer J, Stone M, Marques L, Wilens TE. Different factors identified by stakeholder group for barriers and facilitators to measurement-based care implementation in behavioral health clinics. J Clin Psychol. 2024 Mar; 80(3):576-590. PMID: 38230918; PMCID: PMC10923014; DOI: 10.1002/jclp.23639;

Yule AM, Mail V, Butler R, Wilens TE. Medication Treatment for Youth in Substance Use Disorder Residential Treatment. J Atten Disord. 2024 Mar; 28(5):791-799. PMID: 38166518

Park TW, Baul TD, Morgan JR, Wilens TE, Yule AM. Trends in Attention-Deficit Hyperactivity Disorder Diagnosis and Pharmacotherapy Among Adults With Opioid Use Disorder. Psychiatr Serv. 2024 Mar 01; 75(3):214-220.View Related Profiles.

Yule, Amy
Morgan, Jake
Baul, Tithi

PMID: 37789727

Perry R, Elek E, D'Amico E, Dickerson D, Komro K, Walton M, Razuri EB, Yule AM, Skinner J, Pendergrass T, Larkin K, Johnson C, Bonar EE, Oudekerk BA, Hairgrove S, Liu S, Graham P. Including Community Partners in the Development and Adaptation of Intervention Strategies to Prevent Initiation or Escalation of Opioid Misuse. Prev Sci. 2023 Oct; 24(Suppl 1):61-76. PMID: 37526787; PMCID: PMC10830896; DOI: 10.1007/s11121-023-01575-5;

Rao V, Lanni S, Yule AM, DiSalvo M, Stone M, Berger AF, Wilens TE. Diagnosing major depressive disorder and substance use disorder using the electronic health record: A preliminary validation study. J Mood Anxiety Disord. 2023 Aug; 2. PMID: 37693103; PMCID: PMC10486184; DOI: 10.1016/j.xjmad.2023.100007;

Yule AM, Fernandes CF, Stormshak EA, Yang Y, Shelley L, Fiellin LE, Larkin K, Ridenour TA, Saavedra LM, Kelleher K, Feng X, Walton MA, Bonar EE. Multidisciplinary Strategies for Preventing Opioid Misuse and Escalation by Targeting Mental Health Symptoms and Conditions. Prev Sci. 2023 Oct; 24(Suppl 1):77-87. PMID: 37266870; PMCID: PMC10236392; DOI: 10.1007/s11121-023-01556-8;

McKowen J, Berger A, Towbin J, Yule AM, Woodward D, Nowinski L, Forchelli G, Meyers RJ, Joshi G, Wilens TE. A Manualized Behavioral Therapy Intervention for Youth with Autism Spectrum Disorder and Substance Use Disorder. Case Rep Psychiatry. 2023; 2023:8998160. PMID: 37038552; PMCID: PMC10082677; DOI: 10.1155/2023/8998160;

Showing 10 of 65 results. Show More

Bandla M, Yue H, Mail VR, Villa R, Yule AM. Differences in Behavioral Health Clinician Comfort Discussing Medication to Treat Substance Use Disorders. J Dual Diagn. 2023; 19(2-3):151-152.View Related Profiles.

Yule, Amy
Bandla, Maanasa
Villa, Richard

PMID: 36997171; PMCID: PMC10529499; DOI: 10.1080/15504263.2023.2192054;

Woodward D, Wilens TE, Glantz M, Rao V, Burke C, Yule AM. A systematic review of substance use screening in outpatient behavioral health settings. Addict Sci Clin Pract. 2023 Mar 26; 18(1):18. PMID: 36967381; PMCID: PMC10041696; DOI: 10.1186/s13722-023-00376-z;

Yule AM, Basaraba C, Mail V, Bereznicka A, Cates-Wessel K, Levin FR. A cross sectional survey of provider experiences with patient drug overdose death. J Subst Use Addict Treat. 2023 May; 148:209008. PMID: 36921768; PMCID: PMC10423649; DOI: 10.1016/j.josat.2023.209008;

Woodward D, Wilens TE, Yule AM, DiSalvo M, Taubin D, Berger A, Stone M, Wozniak J, Burke C, Biederman J. Examining the clinical correlates of conduct disorder in youth with bipolar disorder. J Affect Disord. 2023 May 15; 329:300-306. PMID: 36863464; PMCID: PMC10041394; DOI: 10.1016/j.jad.2023.02.119;

Winer JM, Yule AM, Hadland SE, Bagley SM. Addressing adolescent substance use with a public health prevention framework: the case for harm reduction. Ann Med. 2022 Dec; 54(1):2123-2136.View Related Profiles.

Yule, Amy
Bagley, Sarah

PMID: 35900132; PMCID: PMC9341337; DOI: 10.1080/07853890.2022.2104922;

Taubin D, Berger AF, Baek I, DiSalvo M, Wilens TE, Yule AM. Are adolescents and young adults in substance use disorder treatment as engaged in the research recruitment process as those in general behavioral health treatment? Contemp Clin Trials. 2022 Nov; 122:106967. PMID: 36265809; PMCID: PMC9814169; DOI: 10.1016/j.cct.2022.106967;

McKowen JW, Lowman KL, Watt L, Yule AM, Burke C, Kaminiski T, Wilens T, Kelly J. The Relationship Between Cannabis Use and Self-Reported Trait Anger in Treatment-Seeking Young People. Cannabis Cannabinoid Res. 2024 Feb; 9(1):223-229. PMID: 35833834

Wozniak J, DiSalvo M, Farrell A, Yule A, Joshi G, Cook E, Faraone SV, Biederman J. Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole. J Psychopharmacol. 2022 May; 36(5):637-644. PMID: 35510655

Wilens TE, Woodward DW, Ko JD, Berger AF, Burke C, Yule AM. The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders. J Child Adolesc Psychopharmacol. 2022 May; 32(4):200-214. PMID: 35587209; PMCID: PMC9145257; DOI: 10.1089/cap.2022.0016;

Yule AM, Kurtz BP. Children's Mental Health is Important for All Psychiatrists to Address. Focus (Am Psychiatr Publ). 2022 Apr; 20(2):175. PMID: 37153128; PMCID: PMC10153496; DOI: 10.1176/appi.focus.20220041;

Noyes EA, Dunleavy S, Mail V, Plakas I, Keyes S, Gaeta JM, Obando A, Paci E, Lent C, Regis C, Taveras EM, Yule AM, Chatterjee A. Awareness, Utilization, and Preferences of Harm Reduction Interventions among Street-Involved Young Adults in Boston. Subst Use Misuse. 2022; 57(5):827-832.View Related Profiles.

Yule, Amy
Chatterjee, Avik
Paci, Elizabeth
Gaeta, Jessie

PMID: 35195488; PMCID: PMC10372698; DOI: 10.1080/10826084.2022.2040031;

Yue H, Mail V, DiSalvo M, Borba C, Piechniczek-Buczek J, Yule AM. Patient Preferences for Patient Portal-Based Telepsychiatry in a Safety Net Hospital Setting During COVID-19: Cross-sectional Study. JMIR Form Res. 2022 Jan 26; 6(1):e33697.View Related Profiles.

Yule, Amy
Borba, Christina

PMID: 34932497; PMCID: PMC8793913; DOI: 10.2196/33697;

Usher C. Family Matters. J Am Acad Child Adolesc Psychiatry. 2022 04; 61(4):575. PMID: 35065188

McKowen J, Woodward D, Yule AM, DiSalvo M, Rao V, Greenbaum J, Joshi G, Wilens TE. Characterizing autistic traits in treatment-seeking young adults with substance use disorders. Am J Addict. 2022 03; 31(2):108-114. PMID: 34957636

Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA, van de Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle CL, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, Dom G, Eapen V, Faraone SV, Franck J, González RA, Grau-López L, Groenman AP, Hemphälä M, Icick R, Johnson B, Kaess M, Kapitány-Fövény M, Kasinathan JG, Kaye SS, Kiefer F, Konstenius M, Levin FR, Luderer M, Martinotti G, Matthys FIA, Meszaros G, Moggi F, Munasur-Naidoo AP, Post M, Rabinovitz S, Ramos-Quiroga JA, Sala R, Shafi A, Slobodin O, Staal WG, Thomasius R, Truter I, van Kernebeek MW, Velez-Pastrana MC, Vollstädt-Klein S, Vorspan F, Young JT, Yule A, van den Brink W, Hendriks V. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]. Z Kinder Jugendpsychiatr Psychother. 2021 Jan; 50(1):54-67. PMID: 34397296

Yule AM, DiSalvo M, Biederman J, Wilens TE, Dallenbach NT, Taubin D, Joshi G. Decreased risk for substance use disorders in individuals with high-functioning autism spectrum disorder. Eur Child Adolesc Psychiatry. 2023 Feb; 32(2):257-265. PMID: 34363537; PMCID: PMC8936975; DOI: 10.1007/s00787-021-01852-0;

Yule AM, Ijadi-Maghsoodi R, Bagot KS, Bath E. Support for Early-Career Female Physician-Scientists as Part of the COVID-19 Recovery Plan. Acad Med. 2021 May 01; 96(5):e16-e17. PMID: 33315597; PMCID: PMC8068595; DOI: 10.1097/ACM.0000000000003891;

Bentley KH, Sakurai H, Lowman KL, Rines-Toth L, McKowen J, Pedrelli P, Evins AE, Yule AM. Validation of brief screening measures for depression and anxiety in young people with substance use disorders. J Affect Disord. 2021 03 01; 282:1021-1029. PMID: 33601674; PMCID: PMC7896042; DOI: 10.1016/j.jad.2021.01.005;

Hadland SE, Yule AM, Levy SJ, Hallett E, Silverstein M, Bagley SM. Evidence-Based Treatment of Young Adults With Substance Use Disorders. Pediatrics. 2021 01; 147(Suppl 2):S204-S214.View Related Profiles.

Yule, Amy
Silverstein, Michael
Bagley, Sarah
Hadland, Scott

PMID: 33386323; PMCID: PMC7879425; DOI: 10.1542/peds.2020-023523D;

Spencer AE, Valentine SE, Sikov J, Yule AM, Hsu H, Hallett E, Xuan Z, Silverstein M, Fortuna L. Principles of Care for Young Adults With Co-Occurring Psychiatric and Substance Use Disorders. Pediatrics. 2021 01; 147(Suppl 2):229-239.View Related Profiles.

Yule, Amy
Hsu, Heather
Fortuna, Lisa
Silverstein, Michael
Valentine, Sarah

PMID: 33386320; PMCID: PMC8276159; DOI: 10.1542/peds.2020-023523F;

Xuan Z, Choi J, Lobrutto L, Cunningham T, Castedo de Martell S, Cance J, Silverstein M, Yule AM, Botticelli M, Holleran Steiker L. Support Services for Young Adults With Substance Use Disorders. Pediatrics. 2021 01; 147(Suppl 2):S220-S228.View Related Profiles.

Yule, Amy
Silverstein, Michael
Xuan, Ziming

PMID: 33386325; PMCID: PMC9034746; DOI: 10.1542/peds.2020-023523E;

Yule AM, DiSalvo M, Wilens TE, Wozniak J, Faraone SV, Lyons RM, Woodworth KY, Biederman J. High Correspondence Between Child Behavior Checklist Rule Breaking Behavior Scale with Conduct Disorder in Males and Females. Child Psychiatry Hum Dev. 2020 12; 51(6):978-985. PMID: 32172405; PMCID: PMC7492452; DOI: 10.1007/s10578-020-00978-7;

Bagley SM, Hadland SE, Yule AM. A commentary on the impact of COVID-19 on engagement of youth with substance use and co-occurring psychiatric disorders. J Subst Abuse Treat. 2021 02; 121:108175.View Related Profiles.

Yule, Amy
Bagley, Sarah
Hadland, Scott

PMID: 33127195; PMCID: PMC7575435; DOI: 10.1016/j.jsat.2020.108175;

Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA, van de Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle CL, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, Dom G, Eapen V, Faraone SV, Franck J, González RA, Grau-López L, Groenman AP, Hemphälä M, Icick R, Johnson B, Kaess M, Kapitány-Fövény M, Kasinathan JG, Kaye SS, Kiefer F, Konstenius M, Levin FR, Luderer M, Martinotti G, Matthys FIA, Meszaros G, Moggi F, Munasur-Naidoo AP, Post M, Rabinovitz S, Ramos-Quiroga JA, Sala R, Shafi A, Slobodin O, Staal WG, Thomasius R, Truter I, van Kernebeek MW, Velez-Pastrana MC, Vollstädt-Klein S, Vorspan F, Young JT, Yule A, van den Brink W, Hendriks V. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. Eur Addict Res. 2020; 26(4-5):223-232. PMID: 32634814

Wilens TE, Martelon M, Yule A, Kaminski TA, Burke C, Schepis TS, McCabe SE. Disentangling the Social Context of Nonmedical Use of Prescription Stimulants in College Students. Am J Addict. 2020 11; 29(6):476-484. PMID: 32436300; PMCID: PMC7918281; DOI: 10.1111/ajad.13053;

Schiff DM, Nielsen T, Terplan M, Wakeman SE, Yule AM, Mehta PK, Taveras EM, Wilens TE. IMPROVING MEASURES OF DYADIC OUTCOMES IN PERINATAL SUBSTANCE USE RESEARCH. Addiction. 2020 09; 115(9):1787-1788.View Related Profiles.

Yule, Amy
Schiff, Davida

PMID: 32143238

Joshi G, DiSalvo M, Wozniak J, Ceranoglu TA, Yule A, Surman C, Fried R, Galdo M, Hoskova B, Belser A, Biederman J. A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder. World J Biol Psychiatry. 2020 04; 21(4):274-290. PMID: 31607204

Isenberg BM, Yule AM, McKowen JW, Nowinski LA, Forchelli GA, Wilens TE. Considerations for Treating Young People With Comorbid Autism Spectrum Disorder and Substance Use Disorder. J Am Acad Child Adolesc Psychiatry. 2019 12; 58(12):1139-1141. PMID: 31757396

Nielsen T, Bernson D, Terplan M, Wakeman SE, Yule AM, Mehta PK, Bharel M, Diop H, Taveras EM, Wilens TE, Schiff DM. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery. Addiction. 2020 02; 115(2):291-301.View Related Profiles.

Yule, Amy
Schiff, Davida
Bharel, Monica

PMID: 31692133; PMCID: PMC7066531; DOI: 10.1111/add.14825;

Beckmann D, Lowman KL, Nargiso J, McKowen J, Watt L, Yule AM. Substance-induced Psychosis in Youth. Child Adolesc Psychiatr Clin N Am. 2020 01; 29(1):131-143. PMID: 31708042; PMCID: PMC8961695; DOI: 10.1016/j.chc.2019.08.006;

Yule AM, Carrellas NW, DiSalvo M, Lyons RM, McKowen JW, Nargiso JE, Bergman BG, Kelly JF, Wilens TE. Risk Factors for Overdose in Young People Who Received Substance Use Disorder Treatment. Am J Addict. 2019 09; 28(5):382-389. PMID: 31291042; PMCID: PMC6706285; DOI: 10.1111/ajad.12938;

Ameral V, Yule A, McKowen J, Bergman BG, Nargiso J, Kelly JF. A Naturalistic Evaluation of a Group Intervention for Parents of Youth with Substance Use Disorders. Alcohol Treat Q. 2020; 38(3):379-394. PMID: 32863559; PMCID: PMC7451897; DOI: 10.1080/07347324.2019.1633978;

Lyons RM, Yule AM, Schiff D, Bagley SM, Wilens TE. Risk Factors for Drug Overdose in Young People: A Systematic Review of the Literature. J Child Adolesc Psychopharmacol. 2019 08; 29(7):487-497.View Related Profiles.

Yule, Amy
Schiff, Davida
Bagley, Sarah

PMID: 31246496; PMCID: PMC6727478; DOI: 10.1089/cap.2019.0013;

Yule A, Fitzgerald M, Wilens T, Wozniak J, Woodworth KY, Pulli A, Uchida M, Faraone SV, Biederman J. Further Evidence of the Diagnostic Utility of the Child Behavior Checklist for Identifying Pediatric Bipolar I Disorder. Scand J Child Adolesc Psychiatr Psychol. 2019; 7(1):29-36. PMID: 32995342; PMCID: PMC7521745; DOI: 10.21307/sjcapp-2019-006;

Yule AM, Levin FR. Supporting Providers After Drug Overdose Death. Am J Psychiatry. 2019 03 01; 176(3):173-178. PMID: 30818987; PMCID: PMC6436101; DOI: 10.1176/appi.ajp.2018.18070794;

Yule AM, Kelly JF. Integrating Treatment for Co-Occurring Mental Health Conditions. Alcohol Res. 2019 10 24; 40(1). PMID: 31649837; PMCID: PMC6799972; DOI: 10.35946/arcr.v40.1.07;

Surman C, Ceranoglu A, Vaudreuil C, Albright B, Uchida M, Yule A, Spencer A, Boland H, Grossman R, Rhodewalt L, Fitzgerald M, Biederman J. Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical Trial. J Clin Psychopharmacol. 2019 Jan/Feb; 39(1):28-38.View Related Profiles.

Yule, Amy
Spencer, Andrea

PMID: 30566416; PMCID: PMC6750952; DOI: 10.1097/JCP.0000000000000990;

Biederman J, Fitzgerald M, Woodworth KY, Yule A, Noyes E, Biederman I, Faraone SV, Wilens T, Wozniak J. Does the course of manic symptoms in pediatric bipolar disorder impact the course of conduct disorder? Findings from four prospective datasets. J Affect Disord. 2018 10 01; 238:244-249. PMID: 29890451; PMCID: PMC6082174; DOI: 10.1016/j.jad.2018.05.020;

Yule AM, Carrellas NW, Fitzgerald M, McKowen JW, Nargiso JE, Bergman BG, Kelly JF, Wilens TE. Risk Factors for Overdose in Treatment-Seeking Youth With Substance Use Disorders. J Clin Psychiatry. 2018 May/Jun; 79(3). PMID: 29701935; PMCID: PMC6043357; DOI: 10.4088/JCP.17m11678;

Yule AM, Lyons RM, Wilens TE. Opioid Use Disorders in Adolescents-Updates in Assessment and Management. Curr Pediatr Rep. 2018 Jun; 6(2):99-106. PMID: 30895165; PMCID: PMC6422350; DOI: 10.1007/s40124-018-0161-z;

Yule AM, Wilens TE, Martelon M, Rosenthal L, Biederman J. Does exposure to parental substance use disorders increase offspring risk for a substance use disorder? A longitudinal follow-up study into young adulthood. Drug Alcohol Depend. 2018 05 01; 186:154-158. PMID: 29573650; PMCID: PMC5876721; DOI: 10.1016/j.drugalcdep.2018.01.021;

Spencer TJ, Bhide P, Zhu J, Faraone SV, Fitzgerald M, Yule AM, Uchida M, Spencer AE, Hall AM, Koster AJ, Feinberg L, Kassabian S, Storch B, Biederman J. The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone. J Clin Psychiatry. 2018 Mar/Apr; 79(2).View Related Profiles.

Yule, Amy
Spencer, Andrea

PMID: 29617066; PMCID: PMC6548180; DOI: 10.4088/JCP.17m11609;

Spencer TJ, Bhide P, Zhu J, Faraone SV, Fitzgerald M, Yule AM, Uchida M, Spencer AE, Hall AM, Koster AJ, Biederman J. Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone. J Clin Psychiatry. 2018 Jan/Feb; 79(1).View Related Profiles.

Yule, Amy
Spencer, Andrea

PMID: 28640990; PMCID: PMC6438372; DOI: 10.4088/JCP.16m11012;

Yule AM, Kelly JF. Recovery high schools may be a key component of youth recovery support services. Am J Drug Alcohol Abuse. 2018; 44(2):141-142. PMID: 29048934; PMCID: PMC6037163; DOI: 10.1080/00952990.2017.1380033;

Wilens TE, Carrellas NW, Zulauf C, Yule AM, Uchida M, Spencer A, Biederman J. Pilot Data Supporting Omega-3 Fatty Acids Supplementation in Medicated Children with Attention-Deficit/Hyperactivity Disorder and Deficits in Emotional Self-Regulation. J Child Adolesc Psychopharmacol. 2017 10; 27(8):755-756.View Related Profiles.

Yule, Amy
Spencer, Andrea

PMID: 28661708; PMCID: PMC6913100; DOI: 10.1089/cap.2017.0080;

Yule AM, Wilens TE, Rauch PK. The Opioid Epidemic: What Is a Child Psychiatrist to Do? J Am Acad Child Adolesc Psychiatry. 2017 07; 56(7):541-543. PMID: 28647004; PMCID: PMC6082396; DOI: 10.1016/j.jaac.2017.02.011;

Wilens TE, Carrellas NW, Martelon M, Yule AM, Fried R, Anselmo R, McCabe SE. Neuropsychological functioning in college students who misuse prescription stimulants. Am J Addict. 2017 Jun; 26(4):379-387. PMID: 28494131; PMCID: PMC5548389; DOI: 10.1111/ajad.12551;

Yule AM, Martelon M, Faraone SV, Carrellas N, Wilens TE, Biederman J. Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis. J Psychiatr Res. 2017 02; 85:49-55. PMID: 27835739; PMCID: PMC5191927; DOI: 10.1016/j.jpsychires.2016.10.018;

Wilens TE, Biederman J, Martelon M, Zulauf C, Anderson JP, Carrellas NW, Yule A, Wozniak J, Fried R, Faraone SV. Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder. J Clin Psychiatry. 2016 Oct; 77(10):1420-1427. PMID: 27574842; PMCID: PMC6410713; DOI: 10.4088/JCP.14m09440;

Wilens T, Zulauf C, Martelon M, Morrison NR, Simon A, Carrellas NW, Yule A, Anselmo R. Nonmedical Stimulant Use in College Students: Association With Attention-Deficit/Hyperactivity Disorder and Other Disorders. J Clin Psychiatry. 2016 07; 77(7):940-7. PMID: 27464314; PMCID: PMC6438382; DOI: 10.4088/JCP.14m09559;

Wilens TE, Yule A, Martelon M, Zulauf C, Faraone SV. Parental history of substance use disorders (SUD) and SUD in offspring: a controlled family study of bipolar disorder. Am J Addict. 2014 Sep-Oct; 23(5):440-6. PMID: 24628811; PMCID: PMC4139420; DOI: 10.1111/j.1521-0391.2014.12125.x;

Yule AM, Wilens TE, Martelon MK, Simon A, Biederman J. Does exposure to parental substance use disorders increase substance use disorder risk in offspring? A 5-year follow-up study. Am J Addict. 2013 Sep-Oct; 22(5):460-5. PMID: 23952891

Yule AM, Prince JB. Adolescent substance use disorders in the school setting. Child Adolesc Psychiatr Clin N Am. 2012 Jan; 21(1):175-86, xi. PMID: 22137820

Freeman MP, Hibbeln JR, Silver M, Hirschberg AM, Wang B, Yule AM, Petrillo LF, Pascuillo E, Economou NI, Joffe H, Cohen LS. Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial. Menopause. 2011 Mar; 18(3):279-84. PMID: 21037490; PMCID: PMC3195360; DOI: 10.1097/gme.0b013e3181f2ea2e;

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 64 publications over 13 distinct years, with a maximum of 11 publications in 2019

Bar chart showing 64 publications over 13 distinct years, with a maximum of 11 publications in 2019

Year	Publications
2011	1
2012	1
2013	1
2014	1
2016	3
2017	4
2018	6
2019	11
2020	5
2021	8
2022	9
2023	9
2024	5

Media Mentions

Busting 4 Myths About Supporting a Family Member in Addiction Recovery

HealthCity 4/4/2023

Autistic Traits Found in 20% of Young Adults Seeking Addiction Treatment

HealthCity 1/25/2022

Study explores possible autism link in young adults treated for addiction

The Harvard Gazette 1/25/2022

Undiagnosed Autistic Traits Common Among Youths With Substance Use Disorders

Neuroscience News 1/24/2022

Many clinicians feel ill-prepared for drug overdose deaths

Clinical Psychiatry News 12/21/2021

Principles of Providing Recovery Support Services for Young Adults with Substance Use Disorders

HealthCity 1/27/2021

2018 National Institute of Drug Abuse: National Institute of Health Loan Repayment Award in Pediatric Research

2017 American Professional Society of Attention Deficit Hyperactivity Disorder and Related Disorders: Honorable Mention for Poster Tour

2017 MGH Division of Public and Community Psychiatry Symposium: Best Poster

2017 MGH Office for Women’s Careers: Scholarly Writing Award

2017 MGH Center for Faculty Development: Caring for the Dependents Travel Award

2016 American Psychiatric Association: Selected participant for the Research Colloquium for Junior Investigators

2015 MGH Center for Faculty Development: Caring for the Dependents Travel Award

Contact for Mentoring:

720 Harrison Ave
Boston MA 02118
Google Map

617.414.1936

Download vCard

Yule's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (191) concept(s)

Media Mentions

Co-Authors

See all (17) people

Similar People

See all (60) people

Same Department

Search Department